A database analysis of cutaneous lupus erythematosus with the EUSCLE Core Set Questionnaire

Acta Dermato-Venereologica

Volumn 90, Issue 4, 2010, Pages 386-394

  Meuth, Anna Maria ^a   Amler, Susanne ^a   Haust, Merle ^b   Bein, Dennis ^a   Sauerland, Cristina ^a   Köpcke, Wolfgang ^a   Bonsmann, Gisela ^a   Nyberg, Filippa ^c   Kuhn, Annegret ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

ACR criteria; Lupus erythematosus; Questionnaire; Skin

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CORE SET QUESTIONNAIRE; DATA BASE; DISEASE COURSE; FEMALE; GERMANY; HUMAN; MALE; ONSET AGE; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; SKIN LUPUS ERYTHEMATOSUS; SWEDEN; CLASSIFICATION; CLINICAL TRIAL; COMPLICATION; FEASIBILITY STUDY; LUPUS ERYTHEMATOSUS, CUTANEOUS; MIDDLE AGED; MULTICENTER STUDY; PREDICTIVE VALUE; REPRODUCIBILITY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VALIDATION STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; DATABASES AS TOPIC; FEASIBILITY STUDIES; FEMALE; GERMANY; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SWEDEN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77954896184     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0879     Document Type: Article

References (33)

1. Gilliam JN. The cutaneous signs of lupus erythematosus. Cont Educ Fam Phys 1977; 6: 34-70.
2. Gilliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol 1981; 4: 471-475.
3. Gilliam JN, Sontheimer RD. Skin manifestations of SLE. Clin Rheum Dis 1982; 8: 207-218.
4. Provost TT. Nonspecific cutaneous manifestations of systemic lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T, editors. Cutaneous lupus erythematosus. Heidelberg: Springer, 2004: p. 93-106.
5. Costner MI, Sontheimer RD, Provost TT. Lupus erythematosus. In: Sontheimer RD, Provost TT, editors. Cutaneous manifestations of rheumatic diseases. Philadelphia: Williams & Wilkins, 2003: p. 15-64.
6. Kuhn A, Ruzicka T. Classification of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T, editors. Cutaneous lupus erythematosus. Heidelberg: Springer, 2004: p. 53-58.
7. Tebbe B, Orfanos CE. Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 1997; 6: 96-104.
8. Popovic K, Nyberg F, Wahren-Herlenius M. A serology-based approach combined with clinical examination of 125 Ro/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus. Arthritis Rheum 2007; 56: 255-264.
9. The European Medicines Agency. The EMEA recommends the drug candidate ASF-1096 for orphan drug status. Press Release, Astion, 2007.
10. Kuhn A, Kuehn E, Meuth AM, Haust M, Nyberg F, Ruzicka T, et al. Development of a core set questionnaire for the evaluation of cutaneous lupus erythematosus. Autoimmun Rev 2009; 8: 702-712.
11. Cohen AS, Reynolds WE, Franklin EC, Kulka JP, Ropes MW, Shulman LE, et al. Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis 1971; 21: 643-648.
12. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
13. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
14. Albrecht J, Taylor L, Berlin JA, Dulay S, Ang G, Fakharzadeh S, et al. The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus. J Invest Dermatol 2005; 125: 889-894.
15. Albrecht J, Werth VP. Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus. Dermatol Ther 2007; 20: 93-101.
16. Kuhn A, Sonntag M, Richter-Hintz D, Oslislo C, Megahed M, Ruzicka T, et al. Phototesting in lupus erythematosus: a 15-year experience. J Am Acad Dermatol 2001; 45: 86-95. (Pubitemid 32655700)
17. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1993; 72: 113-124.
18. Jimenez S, Cervera R, Ingelmo M, Font J. The epidemiology of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T, editors. Cutaneous lupus erythematosus. Berlin: Springer-Verlag, 2004: p. 45-52.
19. Kuhn A, Richter-Hintz D, Oslislo C, Ruzicka T, Megahed M, Lehmann P. Lupus erythematosus tumidus - a neglected subset of cutaneous Lupus erythematosus: report of 40 cases. Arch Dermatol 2000; 136: 1033-1041.
20. Durosaro O, Davis MD, Reed KB, Rohlinger AL. Incidence of cutaneous lupus erythematosus, 1965-2005: a population-based study. Arch Dermatol 2009; 145: 249-253.
21. Albrecht J, Berlin JA, Braverman IM, Callen JP, Connolly MK, Costner MI, et al. Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus. Lupus 2004; 13: 839-849.
22. Lehmann P, Hölzle E, von Kries R, Plewig G. Diagnostic procedures on patients with Photodermatoses. Zentralblatt Haut- und Geschlechtskrankheiten 1986; 152: 667-682.
23. Sontheimer RD. The lexicon of cutaneous lupus erythematosus - a review and personal perspective on the nomenclature and classification of the cutaneous manifestations of lupus erythematosus. Lupus 1997; 6: 84-95.
24. Alexiades-Armenakas MR, Baldassano M, Bince B, Werth V, Bystryn JC, Kamino H, et al. Tumid lupus erythematosus: criteria for classification with immunohistochemical analysis. Arthritis Rheum 2003; 49: 494-500.
25. Vila LM, Mayor AM, Valentin AH, Rodriguez SI, Reyes ML, Acosta E, et al. Association of sunlight exposure and photoprotection measures with clinical outcome in systemic lupus erythematosus. P R Health Sci J 1999; 18: 89-94.
26. Schmidt E, Tony HP, Brocker EB, Kneitz C. Sun-induced life-threatening lupus nephritis. Ann N Y Acad Sci 2007; 1108: 35-40.
27. Kuhn A, Beissert S. Photosensitivity in lupus erythematosus. Autoimmunity 2005; 38: 519-529.
28. Herzinger T, Plewig G, Rocken M. Use of sunscreens to protect against ultraviolet-induced lupus erythematosus. Arthritis Rheum 2004; 50: 3045-3046.
29. Faurschou A, Wulf HC. The relation between sun protection factor and amount of suncreen applied in vivo. Br J Dermatol 2007; 156: 716-719.
30. Lehmann P. Topical treatment of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T, editors. Cutaneous lupus erythematosus. Berlin: Springer, 2004: p. 337-345.
31. Sardy M, Ruzicka T, Kuhn A. Topical calcineurin inhibitors in cutaneous lupus erythematosus. Arch Dermatol Res 2009; 301: 93-98.
32. Heath M, Raugi GJ. Evidence-based evaluation of immunomodulatory therapy for the cutaneous manifestations of lupus. Adv Dermatol 2004; 20: 257-291.
33. Wenzel J, Bieber T, Uerlich M, Tuting T. Systemic treatment of cutaneous lupus erythematosus. J Dtsch Dermatol Ges 2003; 1: 694-704. (Pubitemid 37205280)